Singapore markets open in 4 hours 59 minutes

Straits Times Index
3,290.70
-2.23(-0.07%)
S&P 500
5,222.68
+94.89(+1.85%)
Dow
39,512.84
+125.04(+0.32%)
Nasdaq
16,340.87
+184.57(+1.14%)
Bitcoin USD
61,374.74
+231.62(+0.38%)
CMC Crypto 200
1,268.68
-43.95(-3.35%)

ETON May 2024 10.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.1000

0.0000

(0.00%)

As of 02:34PM EDT. Market open.

Simply Wall St.
Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
Eton Pharmaceuticals ( NASDAQ:ETON ) First Quarter 2024 Results Key Financial Results Revenue: US$7.97m (up 50% from 1Q...
Thomson Reuters StreetEvents
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
GlobeNewswire
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET DEER PARK, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali